Literature DB >> 25228283

Can sinus anatomy predict quality of life outcomes and operative times of endoscopic frontal sinus surgery?

Adam S DeConde1, Michelle D Barton2, Jess C Mace3, Timothy L Smith4.   

Abstract

PURPOSE: Endoscopic sinus surgery (ESS) can manipulate sinus anatomy, but with limitations due to skull base and orbit anatomy. These anatomical structures dictate the maximal extent of ESS in the frontal recess and may limit surgical extent or operative duration. This study investigates the impact of these anatomical constraints on operative time and quality-of-life (QOL) outcomes.
MATERIALS AND METHODS: Patients with medically refractory chronic rhinosinusitis undergoing Draf IIa frontal sinus surgery were prospectively enrolled. Anatomic measurements of the frontal sinus anatomy were collected during computed tomography review and included: widest distance between the frontal beak and posterior table, narrowest point in the ethmoid bed, Keros height, presence of an anterior ethmoid artery on a mesentery, and presence of inter-sinus septal cells. Primary outcomes included mean operative time and improvement in SinoNasal Outcome Test (SNOT-22) survey scores.
RESULTS: 63 adult participants were enrolled and followed 13.8 (5.2) months on average. The ethmoid bed mean width was 7.2 (1.4) mm, the mean distance from frontal beak to the posterior table at widest was 9.0 (2.7) mm, and mean Keros height was 5.1 (1.8) mm. 49/63 (83.1%) of participants had inter-sinus septal cells and 30/63(50.8%) had anterior ethmoid arteries on a mesentery. Mean operative time was 121.5 (44.0) min while SNOT-22 scores significantly (p<0.001) improved 26.1 (21.6) on average. Anatomic measurements were not predictive of operative time or mean QOL change (p>0.050).
CONCLUSIONS: Frontal sinus surgery is an effective treatment for a range of frontal and ethmoid sinus anatomy. Further study with larger sample size and measures of more restricted anatomy might elucidate treatment limitations of ESS.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25228283      PMCID: PMC4260988          DOI: 10.1016/j.amjoto.2014.08.011

Source DB:  PubMed          Journal:  Am J Otolaryngol        ISSN: 0196-0709            Impact factor:   1.808


  20 in total

Review 1.  Chronic rhinosinusitis: an education and treatment model.

Authors:  Daniel Timperley; Rodney J Schlosser; Richard J Harvey
Journal:  Otolaryngol Head Neck Surg       Date:  2010-08-21       Impact factor: 3.497

2.  Causes of failure in endoscopic frontal sinus surgery in chronic rhinosinusitis patients.

Authors:  Constanza J Valdes; Mariana Bogado; Mark Samaha
Journal:  Int Forum Allergy Rhinol       Date:  2014-03-10       Impact factor: 3.858

3.  Predictors of olfactory dysfunction in rhinosinusitis using the brief smell identification test.

Authors:  Jeremiah A Alt; Jess C Mace; Maria C F Buniel; Zachary M Soler; Timothy L Smith
Journal:  Laryngoscope       Date:  2014-02-10       Impact factor: 3.325

4.  Investigation of change in cardinal symptoms of chronic rhinosinusitis after surgical or ongoing medical management.

Authors:  Adam S DeConde; Jess C Mace; Jeremiah A Alt; Zachary M Soler; Richard R Orlandi; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2014-09-18       Impact factor: 3.858

5.  Comparative effectiveness of medical and surgical therapy on olfaction in chronic rhinosinusitis: a prospective, multi-institutional study.

Authors:  Adam S DeConde; Jess C Mace; Jeremiah A Alt; Rodney J Schlosser; Timothy L Smith; Zachary M Soler
Journal:  Int Forum Allergy Rhinol       Date:  2014-07-12       Impact factor: 3.858

6.  Patient-centered decision making in the treatment of chronic rhinosinusitis.

Authors:  Zachary M Soler; Luke Rudmik; Peter H Hwang; Jess C Mace; Rodney J Schlosser; Timothy L Smith
Journal:  Laryngoscope       Date:  2013-07-15       Impact factor: 3.325

7.  Effects of endoscopic sinus surgery and delivery device on cadaver sinus irrigation.

Authors:  Richard J Harvey; John C Goddard; Sarah K Wise; Rodney J Schlosser
Journal:  Otolaryngol Head Neck Surg       Date:  2008-07       Impact factor: 3.497

8.  Budesonide nasal irrigations in the postoperative management of chronic rhinosinusitis.

Authors:  David W Jang; Vasileios A Lachanas; Jamie Segel; Stilianos E Kountakis
Journal:  Int Forum Allergy Rhinol       Date:  2013-06-17       Impact factor: 3.858

9.  Determinants of outcomes of sinus surgery: a multi-institutional prospective cohort study.

Authors:  Timothy L Smith; Jamie R Litvack; Peter H Hwang; Todd A Loehrl; Jess C Mace; Karen J Fong; Kenneth E James
Journal:  Otolaryngol Head Neck Surg       Date:  2010-01       Impact factor: 3.497

10.  Sleep quality and disease severity in patients with chronic rhinosinusitis.

Authors:  Jeremiah A Alt; Timothy L Smith; Jess C Mace; Zachary M Soler
Journal:  Laryngoscope       Date:  2013-08-05       Impact factor: 3.325

View more
  4 in total

1.  Outcomes of complete vs targeted approaches to endoscopic sinus surgery.

Authors:  Adam S DeConde; Jeffrey D Suh; Jess C Mace; Jeremiah A Alt; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2015-04-23       Impact factor: 3.858

Review 2.  Sino-Nasal outcome test-22 outcomes after sinus surgery: A systematic review and meta-analysis.

Authors:  Zachary M Soler; Rabun Jones; Phong Le; Luke Rudmik; Jose L Mattos; Shaun A Nguyen; Rodney J Schlosser
Journal:  Laryngoscope       Date:  2017-11-22       Impact factor: 3.325

3.  Longitudinal improvement and stability of the SNOT-22 survey in the evaluation of surgical management for chronic rhinosinusitis.

Authors:  Adam S DeConde; Jess C Mace; Jeremiah A Alt; Luke Rudmik; Zachary M Soler; Timothy L Smith
Journal:  Int Forum Allergy Rhinol       Date:  2014-12-15       Impact factor: 3.858

4.  Impact of endoscopic sinus surgery on otologic symptoms associated with chronic rhinosinusitis.

Authors:  Neville W Teo; Jess C Mace; Timothy L Smith; Peter H Hwang
Journal:  World J Otorhinolaryngol Head Neck Surg       Date:  2017-03-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.